Adverse events
diarrhea
PALMAR-PLANTAR ERYTHRODYSESTHESIA
Among the AE endpoints evaluated, exploratory KM plots by exposure quartile indicated an association of cabozantinib exposure with PPE (Grade ≥ 1) and diarrhea (Grade ≥ 3) but not with the other AE endpoints. The exploratory KM plots for PPE (Fig. Kaplan–Meier Plot for Grade ≥ 1 palmar-plantar erythrodysesthesia (